Foundations for blockbuster drugs in federally sponsored research
- 1 August 2001
- journal article
- review article
- Published by Wiley in The FASEB Journal
- Vol. 15 (10) , 1671-1676
- https://doi.org/10.1096/fj.01-0024lsf
Abstract
‘Blockbuster’ drugs, which are widely prescribed and improve the health of millions, often originate in fundamental laboratory research. An important example of such drugs are the cholesterol-lower...Keywords
This publication has 15 references indexed in Scilit:
- Applications of Combinatorial Technologies to Drug Discovery. 2. Combinatorial Organic Synthesis, Library Screening Strategies, and Future DirectionsJournal of Medicinal Chemistry, 1994
- Applications of Combinatorial Technologies to Drug Discovery. 1. Background and Peptide Combinatorial LibrariesJournal of Medicinal Chemistry, 1994
- Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.Proceedings of the National Academy of Sciences, 1980
- Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activityFEBS Letters, 1976
- ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.The Journal of Antibiotics, 1976
- Hypocholesterolemic Agents II: Inhibition of β-Hydroxy-β-methylglutaryl Coenzyme A Reductase by Arylalkyl Hydrogen Succinates and GlutaratesJournal of Pharmaceutical Sciences, 1973
- Hypocholesterolemic Agents I: 3-Methyl-4-phenylbutenoic AcidsJournal of Pharmaceutical Sciences, 1971
- The Biological Synthesis of CholesterolScience, 1965
- Factors of Risk in the Development of Coronary Heart Disease—Six-Year Follow-up ExperienceAnnals of Internal Medicine, 1961
- Über den Gehalt normaler und atheromatöser Aorten an Cholesterin und Cholesterinestern.Hoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1910